Quick Answer
Picard Medical, Inc. reported Cash and Equivalents of $7.45 million for fiscal year 2025.
Picard Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $7.45M | +7661.5% |
| 2024 | $96.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.81M | — | +586.1% |
| June 30, 2025 | $410.0K | — | +327.1% |
| December 31, 2024 | $96.0K | — | — |
- Picard Medical, Inc. showed an increase of +7661.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2024–2025 period, Picard Medical, Inc.’s cash and equivalents has grown by 7661.5% (from $96.0 thousand to $7.45 million).
- The most recent figure is from Picard Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: